Serum prolidase activity and oxidative–antioxidative status in patients with developmental dysplasia of the hip and its relationship with radiographic severity

Redox Report

Volumn 22, Issue 5, 2017, Pages 227-234

  Altay, Mehmet Akif ^a   Ertürk, Cemil ^a   Levent, Ali ^a   Çetin, Baki Volkan ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Developmental dysplasia of the hip; Prolidase enzyme activity; Total antioxidant capacity; Total free sulfhydryl groups; Total oxidant status

Indexed keywords

COLLAGEN; LIPID HYDROPEROXIDE; PROLINE DIPEPTIDASE; THIOL GROUP; ANTIOXIDANT; DIPEPTIDASE; LIPID PEROXIDE; OXIDIZING AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; COLLAGEN METABOLISM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HIP DEVELOPMENTAL DYSPLASIA; HIP DYSPLASIA; HIP RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; BLOOD; CONGENITAL HIP DISLOCATION; DIAGNOSTIC IMAGING; INFANT; METABOLISM;

ANTIOXIDANTS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIPEPTIDASES; FEMALE; HIP DISLOCATION, CONGENITAL; HUMANS; INFANT; LIPID PEROXIDES; MALE; OXIDANTS; OXIDATIVE STRESS;

EID: 84978531259     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1080/13510002.2016.1196873     Document Type: Article

References (28)

1. Ertürk C, Altay MA, Işikan UE. A radiological comparison of Salter and Pemberton osteotomies to improve acetabular deformations in developmental dysplasia of the hip. J Pediatr Orthop B 2013;22:527–32. doi:10.1097/BPB.0b013e32836337cd
2. Herring JA. Tachdjian's pediatric orthopaedics. In:Herring JA (ed.), Developmental dysplasia of the hip. Vol. 1. 5th ed. Philadelphia:Elsevier Saunders Company. Chapter 16, 2014. pp. 483–579.
3. Soran N, Altindag O, Aksoy N, Cakır H, Taşkın A, Soran M, et al. The association of serum prolidase activity with developmental dysplasia of the hip. Rheumatol Int 2013;33(8):1939–42. doi:10.1007/s00296-013-2672-9
4. Altay MA, Erturk C, Aksoy N, Taskın A, Isıkan UE. A preliminary study pointing out the role of serum prolidase activity and oxidative-antioxidative status parameters during the treatment process of patients with idiopathic clubfoot. Scand J Clin Lab Invest 2011;71(7):576–82. doi:10.3109/00365513.2011.596661
5. Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007;27:339–44. doi:10.1007/s00296-006-0247-8
6. Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail 2006;28:271–4. doi:10.1080/08860220600577726
7. Galicka A, Nazaruk J. Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action. Int J Mol Med 2007;20(6):889–95.
8. Altay MA, Erturk C, Aksoy N, Taskin A, Bilge A, Celik H, et al. Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease. J Pediatr Orthop B 2011;20(4):222–6. doi:10.1097/BPB.0b013e32834493df
9. Ertürk C, Altay MA, Selek S, Koçyiğit A. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters. Scand J Clin Lab Invest 2012;72(5):433–9. doi:10.3109/00365513.2012.687116
10. Rahman T, Hosen I, Islam MMT, Shekhar HU. Oxidative stress and human health. Adv Biosci Biotechnol 2012;3:997–1019. doi:10.4236/abb.2012.327123
11. Ertürk C, Altay MA, Yarimpapuç R, Koruk I, Işikan UE. One-stage treatment of developmental dysplasia of the hip in untreated children from two to five years old. A comparative study. Acta Orthop Belg 2011;77(4):464–71.
12. Donnelly KJ, Chan KW, Cosgrove AP. Delayed diagnosis of developmental dysplasia of the hip in Northern Ireland:can we do better? Bone Joint J 2015;97-B(11):1572–6. doi:10.1302/0301-620X.97B11.35286
13. Ozcan O, Gultepe M, Ipcioglu O, Bolat B, Kayadibi H. Optimization of the photometric enzyme activity assay for evaluating real activity of prolidase. Turk J Biochem 2007;32:12–16.
14. Ekin S, Arısoy A, Gunbatar H, Sertogullarindan B, Sunnetcioglu A, Sezen H, et al. The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD. Redox Rep 2016 15:1–4. [Epub ahead of print].
15. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19:319–25. doi:10.1097/MCA.0b013e32830042ba
16. Demirkol A, Uludag M, Soran N, Aksoy N, Gun K, Incebıyık S, et al. Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome. Redox Rep 2012;17:234–8. doi:10.1179/1351000212Y.0000000027
17. Hilali N, Aksoy N, Vural M, Camuzcuoglu H, Taskin A. Oxidative status and serum prolidase activity in tubal ectopic pregnancy. J Pak Med Assoc 2013;63(2):169–72.
18. Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants:when to use the synthetic antioxidants. Oxid Med Cell Longev 2013;2013:956792. doi:10.1155/2013/956792
19. Li Y, Xu H, Li J, Yu L, Liu Y, Southern E, et al. Early predictors of acetabular growth after closed reduction in late detected developmental dysplasia of the hip. J Pediatr Orthop B 2015;24(1):35–39. doi:10.1097/BPB.0000000000000111
20. Eberhardt O, Wirth T, Fernandez FF. Arthroscopic anatomy of the dislocated hip in infants and obstacles preventing reduction. Arthroscopy 2015;31(6):1052–9. doi:10.1016/j.arthro.2014.12.019
21. Rhodes AM, Clarke NM. A review of environmental factors implicated in human developmental dysplasia of the hip. J Child Orthop 2014;8(5):375–9. doi:10.1007/s11832-014-0615-y
22. Staheli LT. Fundamentals of pediatric orthopedics. In:Staheli LT (ed.), Hip and femur. 4th ed. Philadelphia:Wolters Kluwer Health. Chapter 11, 2008. pp. 201–30.
23. Shi D, Dai J, Zhu P, Qin J, Zhu L, Zhu H, et al. Association of the D repeat polymorphism in the ASPN gene with developmental dysplasia of the hip:a case-control study in Han Chinese. Arthritis Res Ther 2011;13:R27. doi:10.1186/ar3252
24. Gold SL, Burge AJ, Potter HG. MRI of hip cartilage:joint morphology, structure, and composition. Clin Orthop Relat Res 2012;470:3321–31. doi:10.1007/s11999-012-2403-7
25. Loder RT, Skopelja EN. The epidemiology and demographics of hip dysplasia. ISRN Orthop 2011; 2011:238607.
26. Zhao L, Tian W, Pan H, Zhu X, Wang J, Cheng Z, et al. Variations of the COL1A1 gene promoter and the relation to developmental dysplasia of the hip. Genet Test Mol Biomarkers 2013;17(11):840–3. doi:10.1089/gtmb.2013.0179
27. Blatt SH. To swaddle, or not to swaddle? Paleoepidemiology of developmental dysplasia of the hip and the swaddling dilemma among the indigenous populations of North America. Am J Hum Biol 2015;27(1):116–28. doi:10.1002/ajhb.22622
28. Karakoc M, Altindag O, Keles H, Soran N, Selek S. Serum oxidative-antioxidative status in patients with ankylosing spondylitis. Rheumatol Int 2007;27:1131–4. doi:10.1007/s00296-007-0352-3